Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection
Clinical trial NCT02500459 · TERMINATED
Trial details
- NCT number
- NCT02500459
- Sponsor
- Michael Vogelbaum, MD, PhD
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-06
- Primary completion
- 2018-11-19
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.